Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P.P. Bapsy
Observed names:
Bapsy P,
Bapsy, PP,
P P Bapsy,
P. Bapsy,
P. P. Bapsy,
Poonamallee P. Bapsy,
Poonamallee Parthasarthy Bapsy
show all 7
Institution:
Kidwai Memorial Institute of Oncology
Observed institutions:
Apollo Hospitals,
Ottawa Hospital,
Kidwai Memorial Institute of Oncology,
Apollo Hospitals,
Apollo Hospitals,
Apollo Hospitals
show all 6
OpenAlex ID:
A5111951037
Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
2014
·
B.K.M. Reddy
, V. Lokesh
, et al.
·
Oral Oncology
·
108
Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma
1997
·
V. Kannan
, Poonamallee P. Bapsy
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
77
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia
2007
·
K. Govind Babu
, Venkata Satya Suresh Attili
, et al.
·
International Ophthalmology
·
54
An open-label, randomized, study of h-R3mAb (nimotuzumab) in patients with advanced (stage III or IVa) squamous cell carcinoma of head and neck (SCCHN): Four-year survival results from a phase IIb study.
2010
·
K. G. Babu
, L. Viswanath
, et al.
·
Journal of Clinical Oncology
·
37
Irreversible sensorineural hearing loss due to Imatinib
2008
·
Venkata Satya Suresh Attili
, P.P. Bapsy
, et al.
·
Leukemia Research
·
29
Mandibular metastasis in hepatocellular carcinoma
1992
·
D.C. Doval
, V. Kannan
, et al.
·
International Journal of Oral and Maxillofacial Surgery
·
17
A phase IIb 4-arm open-label randomized study to assess the safety and efficacy of h-R3 monoclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with advanced (stage III or IVA) inoperable head and neck cancer
2009
·
B. Krishnamurthyreddy
, M. S. Vidyasagar
, et al.
·
Journal of Clinical Oncology
·
12
Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer.
2011
·
Rani James
, K Thriveni
, et al.
·
PubMed
·
11
A Prospective Randomized Study of Chop Versus Chop Plus Alpha-2B Interferon in Patients with Intermediate and High Grade Non-Hodgkin's Lymphoma: The International Oncology Study Group NHL1 Study
2000
·
Francis J. Giles
, Jianqin Shan
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
10
Hepatocellular carcinoma metastatic to bones (Case report with review of literature).
1995
·
D C Doval
, C R Rao
, et al.
·
PubMed
·
10
BIOMAb EGFRTM (Nimotuzumab/h-r3) in Combination With Standard of Care in Squamous Cell Carcinoma of Head and Neck (SCCHN)
2007
·
B.K. Reddy
, M. Vidyasagar
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
9
PDF
Letters to the editor
1996
·
D.C. Doval
, C.R. Rao
, et al.
·
Annals of Oncology
·
9
Clinical utility of serum human epidermal receptor-2/neu detection in breast cancer patients.
2007
·
K Thriveni
, Vijayalakshmi Deshmane
, et al.
·
PubMed
·
8
Safety and efficacy of an indigenous recombinant interferon-alpha-2b in patients with chronic myelogenous leukaemia: results of a multicentre trial from India.
2005
·
Lalit Kumar
, V P Gangadharan
, et al.
·
PubMed
·
8
Uncommon Manifestations of Common Malignancies
2004
·
V. Lakshmi Devi
, Kumar Prabhash
, et al.
·
Journal of Clinical Oncology
·
8
Sino-oral zygomycosis due toAbsidiacorymbiferain a patient with acute leukemia
2004
·
Shafiulla Mohammed
, T. P. Sahoo
, et al.
·
Medical Mycology
·
7
PDF
Imatinib mesylate in newly diagnosed patients of chronic myeloid leukemia chronic phase: A comparative study
2007
·
L. A. Jacob
, P. P. Bapsy
, et al.
·
Journal of Clinical Oncology
·
6
Cytogenetic study of non-Hodgkin lymphoma from South India
2003
·
Prasanna Kumari
, Geetashree Mukherjee
, et al.
·
Cancer Genetics and Cytogenetics
·
6
Risk scoring for predicting mucositis in Indian patients with esophageal carcinoma receiving concurrent chemoradiotherapy.
2009
·
C J Devaraju
, Dasappa Lokanatha
, et al.
·
PubMed
·
5
A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies
2008
·
R. Digumarti
, P. P. Bapsy
, et al.
·
Journal of Clinical Oncology
·
5
Paracentric inv(3)(q21q26) in acute myeloblastic leukemia (M2) with normal thrombopoiesis
1992
·
T.S. Sundareshan
, M. Augustus
, et al.
·
Cancer Genetics and Cytogenetics
·
5
P45 Invasive fungal infections in haematological malignancies at a regional cancer institute – Role of panfungal PCR
2011
·
S. Adurthi
, T.P. Sahoo
, et al.
·
European Journal of Cancer Supplements
·
3
PDF
Malignant myelomatous pleural effusion-Is onset of effusion a new prognostic factor?
2007
·
Suresh Attili
, Batra Ullas
, et al.
·
PubMed
·
3
Clinico-pathologic pattern of gastrointestinal stromal tumors (GIST) in southern India: A single-institution experience
2007
·
M. Lamba
, G. Mukherjee
, et al.
·
Journal of Clinical Oncology
·
3
A Phase IIb, 4 Arm Open-label, Randomized Trial, to Assess the Safety and Efficacy of Concurrent hR3 Monoclonal Antibody against EGF-receptor with Chemoradiation Therapy or with Radiation Therapy in Patients with Advanced (Stage III–IVa), Inoperable Head and Neck Cancer
2009
·
L. Viswanath
, K.B.K.M. Reddy
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Show more works
View as search
Works count:
50
Citation count:
466
H-index:
10
I10-index:
10
Year
Topic
Type
